| 0 (0%) | 02-21 14:30 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 37.73 |
1-year : | 44.07 |
| Resists | First : | 32.31 |
Second : | 37.73 |
| Pivot price | 26.99 |
|||
| Supports | First : | 27.59 |
Second : | 24.67 |
| MAs | MA(5) : | 27.61 |
MA(20) : | 26.99 |
| MA(100) : | 30.77 |
MA(250) : | 22.18 |
|
| MACD | MACD : | -0.7 |
Signal : | -1.1 |
| %K %D | K(14,3) : | 56.3 |
D(3) : | 54.1 |
| RSI | RSI(14): 52.2 |
|||
| 52-week | High : | 39.7 | Low : | 7.75 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ASMB ] has closed below upper band by 8.0%. Bollinger Bands are 33.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 29.04 - 29.16 | 29.16 - 29.26 |
| Low: | 25.73 - 25.86 | 25.86 - 25.97 |
| Close: | 28.5 - 28.74 | 28.74 - 28.94 |
Sat, 21 Feb 2026
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Fri, 20 Feb 2026
Is ASMB a speculative investment - July 2025 Update & Daily Growth Stock Tips - mfd.ru
Tue, 17 Feb 2026
Trading the Move, Not the Narrative: (ASMB) Edition - Stock Traders Daily
Wed, 04 Feb 2026
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above Two Hundred Day Moving Average - What's Next? - MarketBeat
Wed, 24 Dec 2025
With 32% ownership, Assembly Biosciences, Inc. (NASDAQ:ASMB) has piqued the interest of institutional investors - Yahoo Finance
Sun, 21 Dec 2025
Assembly Biosciences (ASMB) Price Target Increased by 24.84% to 48.70 - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 16 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 32.2 (%) |
| Held by Institutions | 56.6 (%) |
| Shares Short | 1,570 (K) |
| Shares Short P.Month | 1,370 (K) |
| EPS | -4.6 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.55 |
| Profit Margin | -103.7 % |
| Operating Margin | -100.9 % |
| Return on Assets (ttm) | -16 % |
| Return on Equity (ttm) | -37 % |
| Qtrly Rev. Growth | 57.5 % |
| Gross Profit (p.s.) | -1.56 |
| Sales Per Share | 2.35 |
| EBITDA (p.s.) | -2.74 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -56 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -6.25 |
| PEG Ratio | 0 |
| Price to Book value | 2.48 |
| Price to Sales | 12.22 |
| Price to Cash Flow | -8.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|